跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,764 条关于
“Oxford Nanopore Technologies”
全部
5,764
临床试验
679
药物
261
机构
317
资讯
4,507
去年
Cepheid and Oxford Nanopore Partner to Revolutionize Infectious Disease Sequencing Workflows
11个月前
Bio-Techne Expands Oxford Nanopore Partnership Through 2032 for Advanced Genetic Diagnostics
6个月前
Oxford Nanopore and Lonza Launch First GMP-Grade Direct RNA Sequencing Solution for mRNA Quality Control
去年
Plasmidsaurus Unveils Three-Day AAV Genome Sequencing Service to Transform Gene Therapy Development
去年
UK Government Partners with Oxford Nanopore to Launch NHS-Wide Pathogen Surveillance System
3个月前
Ultra-Rapid Nanopore Sequencing Reshapes Precision Medicine Across Transplantation, Infectious Disease, and Oncology
3个月前
Single-Cell Multiomics Market to Surge from $2.99 Billion to $18.20 Billion by 2035, Driven by Precision Medicine and AI
3个月前
North America DNA Sequencing Market to Reach $27.56 Billion by 2035, Driven by Precision Medicine and Oncology Applications
去年
Ethris and Lonza Partner to Develop Room-Temperature Stable mRNA Respiratory Vaccines
2年前
Genomics Market Set to Reach $157.47 Billion by 2033, Driven by Personalized Medicine and Government Funding
第 1 页，共 451 页
上一页
下一页
